Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NK Cell Exhaustion
Jiacheng Bi, Zhigang Tian
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 259

Showing 1-25 of 259 citing articles:

The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
Yuanyuan Zhang, Zemin Zhang
Cellular and Molecular Immunology (2020) Vol. 17, Iss. 8, pp. 807-821
Open Access | Times Cited: 1990
CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer
Laura M. McLane, Mohamed S. Abdel-Hakeem, E. John Wherry
Annual Review of Immunology (2019) Vol. 37, Iss. 1, pp. 457-495
Open Access | Times Cited: 1491
Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion
Suchit Jhunjhunwala, Christian Hammer, Lélia Delamarre
Nature reviews. Cancer (2021) Vol. 21, Iss. 5, pp. 298-312
Closed Access | Times Cited: 975
Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation
Karthik Dhatchinamoorthy, Jeff D. Colbert, Kenneth L. Rock
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 680
Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent
Alessio Mazzoni, Lorenzo Salvati, Laura Maggi, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 9, pp. 4694-4703
Open Access | Times Cited: 502
NK Cell Metabolism and Tumor Microenvironment
Iñigo Terrén, Ane Orrantia, Joana Vitallé, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 364
Roles of natural killer cells in immunity to cancer, and applications to immunotherapy
Natalie K. Wolf, Djem Kissiov, David H. Raulet
Nature reviews. Immunology (2022) Vol. 23, Iss. 2, pp. 90-105
Closed Access | Times Cited: 301
Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion
Florida Voli, Emanuele Valli, Luigi Lerra, et al.
Cancer Research (2020) Vol. 80, Iss. 19, pp. 4129-4144
Open Access | Times Cited: 293
Tumor microenvironment: barrier or opportunity towards effective cancer therapy
Aadhya Tiwari, Rakesh Trivedi, Shiaw‐Yih Lin
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 208
Killers 2.0: NK cell therapies at the forefront of cancer control
Jonathan J. Hodgins, S. Khan, Maria M. Park, et al.
Journal of Clinical Investigation (2019) Vol. 129, Iss. 9, pp. 3499-3510
Open Access | Times Cited: 184
Microfluidic tumor-on-a-chip model to evaluate the role of tumor environmental stress on NK cell exhaustion
José M. Ayuso, Shujah Rehman, Marı́a Virumbrales-Muñoz, et al.
Science Advances (2021) Vol. 7, Iss. 8
Open Access | Times Cited: 115
Recent advances and applications of CRISPR-Cas9 in cancer immunotherapy
Zaoqu Liu, Meixin Shi, Yuqing Ren, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 83
Human anti-PSCA CAR macrophages possess potent antitumor activity against pancreatic cancer
Zahir Shah, Lei Tian, Zhixin Li, et al.
Cell stem cell (2024) Vol. 31, Iss. 6, pp. 803-817.e6
Closed Access | Times Cited: 26
T‐bet and Eomes govern differentiation and function of mouse and human NK cells and ILC1
Jiang Zhang, Marie Marotel, Sébastien Fauteux‐Daniel, et al.
European Journal of Immunology (2018) Vol. 48, Iss. 5, pp. 738-750
Open Access | Times Cited: 140
Shedding of CD16 disassembles the NK cell immune synapse and boosts serial engagement of target cells
Katja Srpan, Ashley Ambrose, Alexandros Karampatzakis, et al.
The Journal of Cell Biology (2018) Vol. 217, Iss. 9, pp. 3267-3283
Open Access | Times Cited: 139
NK Cell Dysfunction and Checkpoint Immunotherapy
Jiacheng Bi, Zhigang Tian
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 132
Minimal PD-1 expression in mouse and human NK cells under diverse conditions
Sean J. Judge, Cordelia Dunai, Ethan G. Aguilar, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 6, pp. 3051-3068
Open Access | Times Cited: 126
Evaluating natural killer cell cytotoxicity against solid tumors using a microfluidic model
José M. Ayuso, Regan Truttschel, Max M. Gong, et al.
OncoImmunology (2018) Vol. 8, Iss. 3, pp. 1553477-1553477
Open Access | Times Cited: 123
Unleashing Natural Killer Cells in the Tumor Microenvironment–The Next Generation of Immunotherapy?
Aviad Ben‐Shmuel, Guy Biber, Mira Barda‐Saad
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 117
Targeting Natural Killer Cells for Tumor Immunotherapy
Cai Zhang, Yuan Hu, Chongdeng Shi
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 100
Dendritic Cell Vaccines for Cancer Immunotherapy: The Role of Human Conventional Type 1 Dendritic Cells
João Calmeiro, Mylène A. Carrascal, Adriana Ramos Tavares, et al.
Pharmaceutics (2020) Vol. 12, Iss. 2, pp. 158-158
Open Access | Times Cited: 95
Reduced Nasal Viral Load and IFN Responses in Infants with Respiratory Syncytial Virus Bronchiolitis and Respiratory Failure
Ryan S. Thwaites, Matthew Coates, Kazuhiro Ito, et al.
American Journal of Respiratory and Critical Care Medicine (2018) Vol. 198, Iss. 8, pp. 1074-1084
Open Access | Times Cited: 91
Prognostic value of CD8 + PD-1+ immune infiltrates and PDCD1 gene expression in triple negative breast cancer
Joe Yeong, Jeffrey Chun Tatt Lim, Bernett Lee, et al.
Journal for ImmunoTherapy of Cancer (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 89
Chimeric antigen receptor (CAR) natural killer (NK)‐cell therapy: leveraging the power of innate immunity
Hind Rafei, May Daher, Katayoun Rezvani
British Journal of Haematology (2020) Vol. 193, Iss. 2, pp. 216-230
Open Access | Times Cited: 86
NK-Cell-Mediated Targeting of Various Solid Tumors Using a B7-H3 Tri-Specific Killer Engager In Vitro and In Vivo
Daniel A. Vallera, Soldano Ferrone, Behiye Kodal, et al.
Cancers (2020) Vol. 12, Iss. 9, pp. 2659-2659
Open Access | Times Cited: 77
Page 1 - Next Page

Scroll to top